The doppel (Dpl) protein influences in vitro migration capability in astrocytoma-derived cells

Cellular Oncology

Volumn 30, Issue 6, 2008, Pages 491-501

  Azzalin, Alberto ^a   Sbalchiero, Elena ^a   Barbieri, Giulia ^a   Palumbo, Silvia ^a   Muzzini, Cristina ^a   Comincini, Sergio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antisense oligonucleotide; Gene silencing; Glial tumor; HeLa; IPDDC A2; Migration scratch assay; Prion like proteins; siRNA

Indexed keywords

PRION PROTEIN; PROTEIN DOPPEL; SMALL INTERFERING RNA; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

ASTROCYTOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; HELA CELLS; HUMANS; PRIONS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 54249165890     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2008-0437     Document Type: Article

References (57)

1. C proteins in human tumor astrocytic cells, Anticancer Research 25 (2005), 4369-4374.
2. A. Azzalin, I. Del Vecchio, L. Ferretti et al., The prion-like protein doppel (Dpl) interacts with the human receptor for activated C-kinase 1 (RACK1) protein, Anticancer Research 26 (2006), 4539-4548.
3. G. Bacciocchi, N. Gibelli, C. Zibera et al., Establishment and characterization of two cell lines derived from human glioblastoma multiforme, Anticancer Research 12 (1992), 853-861.
4. A.J. Balmfort, S.G. Ball, R.I. Freshney et al., D-1 dopaminergic and β-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM, Journal Neurochemistry 47 (1986), 715-719.
5. A. Behrens and A. Aguzzi, Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl, Trends in Neuroscience 25 (2002), 150-154.
6. A. Behrens, S. Brandner, N. Genoud et al., Absence of the prion protein homologue doppel causes male sterility, EMBO Journal 21 (2002), 3652-3658.
7. V.P. Collins, Mechanisms of disease: genetic predictors of response to treatment in brain tumors, Nature Clinical Practice Oncology 4 (2006), 362-374.
8. S. Comincini, L.R. Chiarelli, P. Zelini et al., Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells, Oncology Reports 16 (2006), 1325-1332.
9. S. Comincini, I. Del Vecchio and A. Azzalin, The doppel gene biology: a scientific journey from brain to testis, and return, Central European Journal of Biology 1 (2006), 494-505.
10. S. Comincini, A. Facoetti, I. Del Vecchio et al., Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression, Anticancer Research 24 (2004), 1507-1517.
11. S. Comincini, V. Ferrara, A. Arias et al., Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy, Oncology Reports 17 (2007), 989-996.
12. D.R. Corey, RNA learns from antisense, Nature Chemical Biology 3 (2007), 8-11.
13. E.A. Cox, D. Bennin, A.T. Doan et al., RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site, Molecular Biology of the Cell 14 (2003), 658-669.
14. I. Del Vecchio, A. Azzalin, E. Guidi et al., Functional mapping of the bovine doppel gene promoter region, Gene 356 (2005), 101-108.
15. T. Demuth and M.E. Berens, Molecular mechanisms of glioma cell migration and invasion, Journal of Neuro-Oncology 70 (2004), 217-228.
16. T. Demuth, J.L. Rennet, D.B. Hoelzinger et al., Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines, BMC Genomics 29 (2008), 9-54.
17. F. Fagotto and B.M. Gumbiner, Cell contact-dependent signaling, Developmental Biology 180 (1996), 445-454.
18. A. Giese, R. Bjerkvig, M.E. Berens et al., Cost of migration: invasion of malignant gliomas and implications for treatment, Journal Clinical Oncology 21 (2003), 1624-1636.
19. A. Giese, M.A. Loo, N. Tran et al., Dichotomy of astrocytoma migration and proliferation, International Journal of Cancer 67 (1996), 275-282.
20. B.M. Gumbiner, Cell adhesion: the molecular basis of tissue architecture and morphogenesis, Cell 84 (1996), 345-357.
21. D.B. Hoelzinger, L. Mariani, J. Weis et al., Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets, Neoplasia 7 (2005), 7-16.
22. R.O. Hynes, Cell adhesion: old and new questions, Trends in Genetics 15 (1999), M33-M37.
23. K. Ichimura, H. Ohgaki, P. Kleihues et al., Molecular pathogenesis of astrocytic tumours, Journal of Neuro-Oncology 70 (2004), 137-160.
24. K.R. Jessen, Glial cells, International Journal of Biochemistry & Cell Biology 36 (2004), 1861-1867.
25. A. Kalota, Progress in the development of nucleic acid therapeutics for cancer, Cancer Biology & Therapy 3 (2004), 4-12.
26. P.A. Kiely, D. O'Gorman, K. Luong et al., Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and β1 integrin to promote cell migration, Molecular and Cellular Biology 26 (2006), 4041-4051.
27. F. Lefranc, J. Brotchi and R. Kiss, Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis, Journal of Clinical Oncology 23 (2006), 2411-2422.
28. A. Li, S. Sakaguchi, R. Atarashi et al., Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene, Cellular and Molecular Neurobiology 20 (2000), 553-567.
29. I. Lopez de Silanes, M.P. Quesada and M. Esteller, Aberrant regulation of messenger RNA 3′-untraslated region in human cancer, Cellular Oncology 29 (2007), 1-17.
30. D.N. Louis, H. Ohgaki, O.D. Wiestler et al., The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathologica 114 (2007), 97-109.
31. T. Lührs, R. Riek, P. Güntert et al., NMR structure of the human doppel protein, Journal of Molecular Biology 326 (2003), 1549-1557.
32. M. Lynch and S. Conery, The evolutionary fate and consequences of duplicate genes, Science 290 (2000), 1151-1155.
33. E. Makrinou, J. Collinge and M. Antoniou, Genomic characterization of the human prion protein (PrP) gene locus, Mammalian Genome 13 (2002), 696-703.
34. P. Mastrangelo and D. Westaway, The prion gene complex encoding PrPC and Doppel insights from mutational analysis, Gene 275 (2001), 1-18.
35. A. Matsuno and T. Nagashima, Specific gene suppression using antisense strategy for growth suppression of glioma, Medical Electron Microscopy 37 (2004), 158-161.
36. S. Mead, J. Beck, A. Dickinson et al., Examination of the human prion protein-like gene Doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease, Neuroscience Letters 290 (2000), 117-120.
37. P.S. Mischel, T.F. Cloughesy and S.F. Nelson, DNA-microarray analysis of brain cancer: molecular classification for therapy, Nature Review Neuroscience 5 (2004), 782-792.
38. R.C. Moore, I.Y. Lee, G.L. Silverman et al., Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel, Journal of Molecular Biology 292 (1999), 797-817.
39. M. Nakada, S. Nakada, T. Demuth et al., Molecular targets of glioma invasion, Cellular and Molecular Life Sciences 64 (2007), 458-478.
40. H. Ohgaki and P. Kleihues, Genetic pathways to primary and secondary glioblastoma, American Journal of Pathology 170 (2007), 1445-1453.
41. K. Peoc'h, C. Serres, Y. Frobert et al., The human "prion-like" protein Doppel is expressed in both Sertoli cells and spermatozoa, Journal of Biological Chemistry 277 (2002), 43071-43078.
42. J. Pontén and E.H. Macintyre, Long term culture of normal and neoplastic human glia, Acta Pathologica et Microbiologica Scandinavica 74 (1968), 465-486.
43. S.B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science 216 (1982), 136-144.
44. D.A. Reardon, J.N. Rich, H.S. Friedman et al., Recent advances in the treatment of malignant astrocytoma, Journal of Clinical Oncology 24 (2006), 1253-1264.
45. E. Sahai, Mechanisms of cancer cell invasion, Current Opinion in Genetics & Development 15 (2005), 87-96.
46. S. Sathornsumetee and J.N. Rich, New treatment strategies for malignant gliomas, Expert Review of Anticancer Therapy 6 (2006), 1087-1104.
47. E. Sbalchiero, A. Azzalin, S. Palumbo et al., Altered cellular distribution and sub-cellular sorting of doppel (Dpl) protein in human astrocytoma cell lines, Cellular Oncology 30 (2008), 337-347.
48. D. Schechtman and D. Mochly-Rosen, Adaptor proteins in protein kinase C-mediated signal transduction, Oncogene 20 (2001), 6339-6347.
49. F. Shi and D. Hoekstra, Effective intracellular delivery of oligonucleotides in order to make sense of antisense, Journal of Controlled Release 97 (2004), 189-209.
50. I. Tamm, Antisense therapy in malignant diseases: status quo and quo vadis?, Clinical Science 110 (2006), 427-442.
51. M.A. Tranulis, A. Espenes, S. Comincini et al., The PrP-like protein doppel gene in sheep and cattle: cDNA sequence and expression, Mammalian Genome 12 (2001), 376-379.
52. N.L. Tuzi, E. Gall, D. Melton et al., Expression of doppel in the CNS of mice does not modulate transmissible spongiform encephalopathy disease, Journal of General Virology 83 (2002), 705-711.
53. C. Uboldi, I. Del Vecchio, M.G. Foti et al., Prion-like doppel gene (PRND) in the goat: genomic structure, cDNA, and polymorphisms, Mammalian Genome 16 (2005), 963-971.
54. A. Valster, N.L. Tran, M. Nakada et al., Cell migration and invasion assays, Methods 37 (2005), 208-215.
55. M. Vicente-Manzanares, D.J.Webb and A.R. Horwitz, Cell migration at a glance, Cell Science 118 (2005), 4917-4919.
56. C. Weissmann and A. Aguzzi, Perspectives: neurobiology. PrP's double causes trouble, Science 286 (1999), 914-915.
57. H. Yamaguchi, J. Wyckoff and J. Condeelis, Cell migration in tumors, Current Opinion in Cellular Biology 17 (2005), 559-564.